Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
Enzymatic wound debridement therapy derived from maggot biology
SolasCure is a biotechnology company developing a recombinant enzyme-based hydrogel for the treatment of chronic wounds. The lead product contains a protease cloned from medical…
Oncology biotech developing peptide therapeutics and diagnostics
ValiRx is a UK-listed biopharmaceutical company focused on the development of oncology therapeutics and companion diagnostics. The company selects and incubates novel drug…
AI platform generating novel therapeutic proteins for biotech partners
Latent Labs is a UK-based developer of artificial intelligence models that generate entirely new therapeutic proteins not found in nature. Building on foundational AI…
Peptide discovery platform targeting cell-surface therapeutic targets
Orbit Discovery is a drug discovery company providing peptide lead identification services using a proprietary bead-based peptide display engine combined with microfluidic…
AI-driven neural data platform for bioelectronic medicine
BIOS Health is a neural engineering company developing an AI-powered platform that reads and interprets peripheral nervous system signals in real time. Its technology links nerve…
Preclinical and clinical CRO specialising in biomarker services
Epistem is a contract research organisation providing preclinical and clinical research services to pharmaceutical and biotechnology companies. Its capabilities span in vivo and…
AAV gene therapy platform targeting podocyte-mediated kidney disease
Purespring Therapeutics is a clinical-stage biotech developing AAV-based gene therapies for chronic kidney disease. Its platform delivers therapeutic transgenes directly to…
Benchtop platform for rapid cell-free protein expression and screening
Nuclera is a Cambridge-based biotechnology company developing benchtop systems for rapid protein expression and screening. Its discovery platform integrates cell-free protein…
Precision medicine biotech targeting psychiatric and neurological conditions
Monument Therapeutics is a clinical-stage biotechnology company applying precision medicine to CNS drug development. The company uses proprietary digital biomarkers to stratify…
Mitochondrial sulfide-donor therapeutics for obesity and myopathies
MitoRx Therapeutics is a company developing first-in-class small molecule therapeutics that target mitochondrial sulfide signalling, a mechanism implicated in metabolic…
National facility for mouse genetics and preclinical disease modelling
The Mary Lyon Centre at MRC Harwell is the UK's national centre for mouse genetics, providing mouse model generation, phenotyping, cryopreservation, and archiving services to…
Takeda's UK clinical development and drug discovery operations
Takeda UK encompasses the British operations of Takeda Pharmaceutical Company, one of the world's largest biopharmaceutical companies. The London-based Takeda Development Centre…